PCI
GILD icon

Planning Center Inc’s Gilead Sciences GILD Stock Holding History

Planning Center Inc’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-1,437
Closed -$200K – 86
2026
Q1 		$200K Buy
+1,437
New +$201K 0.02% 77

Other funds holding GILD

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

Planning Center Inc's GILD Position: Q2 2026 in Review

Planning Center Inc sold out of Gilead Sciences (GILD) in Q2 2026, closing a stake of 1,437 shares — an estimated $200K sold.

Planning Center Inc first reported a position in GILD in Q1 2026 and held it in 1 quarter. The position peaked at $200K in Q1 2026. 1,032 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Planning Center Inc reported no remaining Gilead Sciences position as of Q2 2026 after selling out during the quarter.
  • Planning Center Inc sold 1,437 Gilead Sciences shares in Q2 2026, an estimated $200K.
  • Planning Center Inc first reported a position in Gilead Sciences in Q1 2026 and held it in 1 quarter.
  • Planning Center Inc's Gilead Sciences position peaked at $200K in Q1 2026.
  • 1,032 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Planning Center Inc's 13F filing for Q2 2026, filed 30 Jul 2026.